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Background: Glyceraldehyde-3-phosphate dehydrogenase is a pivotal glycolytic enzyme and implicated in many human
cancers.
Results: GAPDH acetylation promotes its activity in response to glucose via the action of PCAF and HDAC5.
Conclusion: GAPDH acetylation promotes cell proliferation and tumor growth.
Significance: This study demonstrates a critical role of GAPDH acetylation in tumor growth and provides potential therapy
target for cancer.
The altered metabolism in most tumor cells consists of ele-
vated glucose uptake and increased glycolysis even in the pres-
ence of high oxygen tension. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) is an obligatory enzyme in glycolysis.
Here, we report that acetylation at lysine 254 (K254) increases
GAPDH activity in response to glucose. Furthermore, acetyla-
tion of GAPDH (K254) is reversibly regulated by the acetyl-
transferase PCAF and the deacetylase HDAC5. Substitution of
K254 to glutamine compromises the ability of GAPDH to sup-
port cell proliferation and tumor growth. Our study reveals a
mechanism of GAPDH enzyme activity regulation by acetyla-
tion and its critical role in cellular regulation.
Most cancer cells rely on aerobic glycolysis, instead of mito-
chondrial oxidative phosphorylation, to generate the energy
and metabolic intermediates needed for cellular processes,
resulting in increased glucose uptake and consumption. This
phenomenon, which is coined as “the Warburg effect” (1), pro-
vides the basis to image tumors in clinics using 2-(18F)-fluoro-2-
deoxy-D-glucose (18F-FDG)2 by positron emission tomography
(PET). 18F-FDG-PET combined with computer tomography (CT)
is widely used for detecting most epithelial tumors (2, 3). Signifi-
cantly elevated levels of glycolytic enzymes were observed in most
human cancers (4).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an
enzyme in glycolysis. GAPDH specifically catalyzes the simul-
taneous phosphorylation and oxidation of glyceraldehyde
3-phosphate using nicotinamide adenine dinucleotide (NAD)
as a cofactor to produce glycerate 1,3-biphosphate and NADH.
GAPDH is located mainly in the cytoplasm and primarily
exists as a tetrameric structure composed of four identical 37
kDa subunits. GAPDH was once considered as a simple
“housekeeping” protein and frequently used as a control in pro-
tein and gene studies, a number of studies however showed that
the GAPDH gene and protein are actively regulated in cell pro-
liferation (5, 6). In addition to its role in energy production,
GAPDH has been implicated in many cellular processes includ-
ing DNA repair (7), tRNA export (8), membrane fusion and trans-
port (9), endocytosis and nuclear membrane assembly (10), and
cell death (11, 12). Recently elegant studies also found GAPDH is
involved in immunity (13) and senescence (14). The diverse func-
tions of GAPDH are mainly regulated by its oligomerization, post-
translational modification and sub-cellular localization.
Protein acetylation is a reversible post-translational modifi-
cation, which has been recently identified as being broadly
involved in the regulation of many cellular processes. In addi-
tion, several acetylation proteomics studies reported more than
2000 potential acetylation nonnuclear substrates (15–17). Most
enzymes in glycolysis, including GAPDH, are acetylated in
liver. In this study we investigated the GAPDH acetylation and
its functional role in cellular proliferation and tumor growth.
EXPERIMENTAL PROCEDURES
Deacetylase Inhibitor Treatment—Deacetylase inhibitor treat-
ments were carried out by adding TSA (0.5 mM) and NAM (5
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mM) to the culture medium 18 and 6 h before harvesting,
respectively; both concentrations are final concentrations in
the culture medium.
Immunoprecipitation (IP) and Western Blotting Analysis—
Protein lysate were prepared from HEK 293T, A549, and stable
pool cells in a buffer containing 50 mM Tris-HCl (pH 7.5), 150
mM NaCl, 0.1% Nonidet P-40, and a mixture of protease inhib-
itors (Roche Applied Science). For IP experiments, 500 g of
cell lysate were incubated with anti-Flag M2-agarose for 3 h at
4 °C. Beads were washed three times with lysis buffer and cen-
trifuged at 2,000  g for 2 min between each wash. The Flag-
tagged proteins were eluted by Flag peptides (Gilson Biochem-
ical). Lysate was resolved on 8 –10% SDS-PAGE and transferred
onto nitrocellulose membrane (Bio-Rad) for Western blotting
analysis. Antibodies to FLAG (catalogue no. A00170 from Gen-
Script or catalogue no. A2220 from Sigma), GAPDH (used for
IP, 5632-1, Epitomics; 1:100), GAPDH (6C5) (SC32233, Santa
Cruz Biotechnology), HA (F7) (SC7392, Santa Cruz Biotech-
nology), and -actin (13E5) (no. 4970, Cell Signaling) were pur-
chased commercially.
Measurement of GAPDH Activity—The GAPDH assay was
carried out as G9263-Enzyme Assay and followed the manufac-
turer’s instruction (Sigma Aldrich).
In Vitro Deacetylation Assay—CobB was expressed in Esch-
erichia coli, purified with nickel beads, and stored at 80 °C in
10% glycerol. For in vitro deacetylation assay, 10 g CobB and
GAPDH was added into the buffer (40 mM HEPES (pH 7.0), 6
mM MgCl2, 1 mM NAD, and 1 mM DTT) at 37 °C for 1 h.
Cell Proliferation Analysis— 4  104 cells were seeded in trip-
licate in 6-well plates, and cell numbers were counted every 24 h
over a 5-day period using Cellometer Auto T4 and followed the
manufacturer’s instruction (Nexcelom Bioscience).
Cell Counting Kit-8 (CCK-8) Assay—2000 cells were seeded
in triplicate in 96-well plates, and add 10 l of CCK-8 solution
to each well of the plate and incubate the cells for 2 h. Measure
the absorbance at 450 nm using a microplate reader (Elx 800,
Biotek instruments).
Xenograft Studies—BALB/C-Nude mice (nu/nu, male,
4-weeks old) were injected subcutaneously with 5  106 A549
cells. Around 7 weeks after injection, the tumors were dissected
and weighed.
RESULTS
GAPDH Is Acetylated at Lysine 254—Several acetylation pro-
teomic studies identified GAPDH as a putative substrate of
acetylation. To confirm this observation, we transfected Flag-
GAPDH into HEK 293T cells and analyzed GAPDH acetylation
by the pan anti-acetyl lysine antibody and found that GAPDH
was indeed acetylated. Furthermore, Flag-GAPDH acetylation
level was enhanced by over 3-fold after treatment with tricho-
statin A (TSA), an inhibitor of histone deacetylase (HDAC)
class I and class II, and Nicotinamide (NAM), an inhibitor of the
SIRT family deacetylase (Fig. 1A). Moreover, endogenous
GAPDH was purified, and GAPDH acetylation was analyzed.
We found that the acetylation level increased more dramati-
cally by TSA (3.1-fold) than by NAM (1.2-fold) (Fig. 1B). These
results indicate that both exogenously and endogenously
expressed GAPDH are acetylated.
Acetylation of K254 in peptide RLEKPAKAcYDDIKK was hit
five times with a high score and matched the human GAPDH
sequence with acetylation at K254 by two different proteomic
studies (15, 17). Notably, K254 in GAPDH is conserved from
Danio rerio to Homo sapiens (Fig. 1C). To identify whether
K254 is indeed acetylated, we mutated lysine 254 individually
to glutamine (Q) or arginine (R) and examined their acetylation
by using the pan anti-acetyl lysine antibody and found that
mutations of K254 resulted in a significant reduction in
GAPDH acetylation (Fig. 1D). To further confirm the acetyla-
tion of K254, we transfected GAPDH wild-type (WT) and
mutants into HEK 293T cells and treated the cells with NAM
and TSA or not. Then we measured GAPDH acetylation and
found the inhibition of deacetylases increased the acetylation
level of GAPDH WT, but not the mutants of K254Q and K254R
(Fig. 1D), indicating that under this condition, K254 is the
major acetylation site of GAPDH.
To determine if K254 is acetylated in vivo, we generated a
site-specific antibody against an acetylated K254 GAPDH pep-
tide (VVDLTCRLEKPAKAcYDDIKKVVKQAS). The specific-
ity of the anti-AcGAPDH (K254) antibody was first confirmed
by its ability to recognize the K254 acetylated, but not the
unmodified peptide (Fig. 1E). The peptide blocking experiment
showed K254-acetylated GAPDH absorbed anti-AcGAPDH
(K254) antibody (Fig. 1F). This antibody strongly recognized
the ectopically expressed WT GAPDH, but only weakly recog-
nized the K254 mutated GAPDH (Fig. 1G), confirming the
specificity of the antibody. Next, we used the anti-AcGAPDH
(K254) antibody to detect endogenous GAPDH acetylation. We
identified a band of expected molecular weight for GAPDH in
Chang’s liver cell lysate, which was diminished when the anti-
body was pre-incubated with competing antigen peptide or
when the endogenous GAPDH was knocked down (Fig. 1H).
Lysate of HEK 293T cells treated with or without NAM and
TSA were analyzed by Western blotting using the anti-Ac-
GAPDH (K254) antibody. The acetylation level of K254 was
increased by nearly 3-fold after the inhibition of deacetylase
(Fig. 1I). Together, these characterizations demonstrated
GAPDH is acetylated at K254.
Inhibition of Deacetylase Increases GAPDH Activity—Acety-
lation has several different mechanisms in regulating metabolic
enzymes (18). To determine the effect of K254 acetylation on
GAPDH, we measured GAPDH enzyme activity. Flag-GAPDH
was transfected into HEK 293T cells and the transfected cells
were treated with or without TSA and NAM. Flag-GAPDH was
immunoprecipitated, and enzyme activity was measured in
vitro. We observed that the GAPDH activity was increased over
40% in the TSA and NAM treated cells (Fig. 2A). As expected,
NAM and TSA treatment also increased the acetylation level of
Flag-GAPDH. Compared with TSA, NAM had a much weaker
effect (Fig. 2B). The above results suggest that a TSA-sensitive
member of class I and/or II HDAC regulates GAPDH acetyla-
tion and activity.
Acetylation Increases GAPDH Enzyme Activity—To deter-
mine the effect of K254 acetylation, we measured the activity of
WT and K254 mutants GAPDH in the presence or absence of
TSA. The K254Q mutant displayed activity slightly higher than
the WT GAPDH whereas the K254R mutant has activity indis-
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tinguishable from that of the WT enzyme (Fig. 2C). In contrast
to the WT GAPDH that was strongly activated by TSA, a sim-
ilar TSA treatment had little effect on the activity of either
GAPDHK254Q or GAPDHK254R mutants (Fig. 2C). This result
suggests that acetylation of K254 is responsible for GAPDH
activation, although K254Q mutant did not mimic the effect of
acetylation. To further determine the function of acetylation in
GAPDH activity regulation, we incubated the purified Flag-
FIGURE 1. GAPDH is acetylated at lysine 254. A, exogenous GAPDH is acetylated. Flag-GAPDH was expressed in HEK 293T cells followed by treatment with or
without deacetylase inhibitors NAM and TSA. The acetylation and protein levels were analyzed by Western blot. Relative ratios of GAPDH acetylation were
calculated from normalizing against Flag-GAPDH. B, endogenous GAPDH is acetylated. Endogenous GAPDH protein was purified from HEK 293T cells after
NAM and TSA treatment as indicated. The acetylation and protein levels were analyzed by Western blot. Relative ratios of GAPDH acetylation were calculated
from normalizing against GAPDH. C, K254 site in GAPDH is conserved. The sequences around K254 from different species were aligned. Conserved lysine
residues corresponding to human GAPDH K254 are bolded. D, inhibition of deacetylase increases the acetylation level of wild-type (WT), but not the mutants
of GAPDH. GAPDH was expressed in HEK 293T cells and affinity purified, followed by Western blot. Relative ratios of GAPDH acetylation were calculated from
normalizing against Flag-GAPDH. E, specificity of the antibody was determined by dot blot. Nitrocellulose membrane was spotted with different amounts of
either acetyl-K254 peptide or unmodified peptide and probed with anti-AcGAPDH (K254) antibody. F, K254-acetylated GAPDH peptide can absorb the
acetyl-K254 antibody. The anti-AcGAPDH (K254) antibody was incubated with acetylated peptide or unmodified peptide for 1 h and used for Western blotting
as indicated. G, GAPDH was expressed in HEK 293T cells and affinity-purified protein was measured by Western blot using anti-AcGAPDH (K254) antibody or
pre-immune serum. H, cell lysate from scramble or GAPDH shRNA knockdown stable cells were probed. I, endogenous GAPDH is acetylated at K254. HEK 293T
cells were treated with NAM and TSA. The protein levels and acetylation of K254 were determined by Western blot. Relative ratios of GAPDH K254 acetylation
were calculated from normalizing against GAPDH.
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GAPDH with the bacterial deacetylase CobB. NAD is a co-
factor required for CobB-catalyzed deacetylation. As expected,
CobB could not deacetylate nor inhibit GAPDH activity in the
absence of NAD. GAPDH activity decreased by as much as
65% by CobB, this reduction is associated with almost complete
loss of K254 acetylation (Fig. 2D). Collectively, these results
provide convincing in vitro biochemical evidence that demon-
strating K254 acetylation increases GAPDH catalytic activity.
PCAF Acetylates GAPDH at K254—To determine the acetyl-
transferase responsible for GAPDH K254 acetylation, we
transfected four acetyltransferases, p300 (E1A-binding protein
300kD), CBP (cAMP response element-binding protein
(CREB)-binding protein), PCAF (p300/(CREB-binding pro-
tein)-associated factor), and GCN5 (KAT2A), individually into
HEK 293T cells and observed GAPDH K254 acetylation. We
found that only PCAF transfection increased endogenous
GAPDH acetylation at K254 by nearly 3-fold, while the other
three acetyltransferases had little effect (Fig. 3A). Co-expres-
sion experiments also showed the enhancement of K254 acety-
lation of exogenously expressed GAPDH by PCAF (Fig. 3B). To
complement the transfection data, PCAF was knocked-down
by small interfering RNA (siRNA). The knock down efficiency
was measured by qPCR and Western blotting analysis. Knock-
ing down PCAF significantly reduced K254 acetylation level
(Fig. 3C). These data indicate that PCAF is a potential K254
acetyltransferase in vivo. To determine if PCAF can interact
with GAPDH, we co-transfected Flag-PCAF and Myc-GAPDH
into HEK 293T cells, and proteins were purified by anti-Flag
beads. We found that PCAF interacted with GAPDH (Fig. 3D).
Furthermore, the endogenous GAPDH could be readily
detected in a PCAF immune-complex derived from HEK 293T
cells (Fig. 3E), demonstrating a physical association between
GAPDH and PCAF in vivo. We also found that PCAF co-ex-
pression increased the enzyme activity of GAPDH WT, but had
no significant effect on the activity of GAPDH mutants (Fig.
3F), indicating that PCAF stimulates GAPDH activity mostly
via acetylation of K254. Furthermore, knocking down PCAF
significantly reduced GAPDH activity by more than 50% (Fig.
FIGURE 2. Acetylation at K254 increases GAPDH enzyme activity. A, acetylation increases GAPDH enzyme activity. Flag-GAPDH was expressed in HEK 293T
cells followed by treatment with NAM and TSA, and GAPDH acetylation and protein levels were analyzed by Western blot. The enzyme activity was measured
and normalized against protein level. Mean values of relative enzyme activity of triplicate experiments S.D. are presented. B, TSA increases GAPDH enzyme
activity more dramatically than NAM. Flag-GAPDH was expressed in HEK 293T cells followed by treatment with NAM or TSA, acetylation levels and enzyme
activity of GAPDH were determined as A. C, inhibition of deacetylase increases the enzyme activity of WT, but not mutants of GAPDH. The indicated plasmids
were expressed in HEK 293T cells with or without TSA treatment and purified by IP, acetylation levels and enzyme activity of GAPDH were determined as A. D,
CobB decreases GAPDH acetylation level and enzyme activity. GAPDH was expressed in HEK 293T cells, affinity purified and incubated with or without
recombinant CobB at the presence of NAD or not. Different samples were analyzed for acetylation levels and enzyme activities as A.
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3G). Taken together, the above data support a model that PCAF
may be one of the acetyltransferases of GAPDH and PCAF
acetylates GAPDH at K254.
HDAC5 Deacetylates GAPDH at K254—Because TSA, but
not NAM, significantly increased GAPDH acetylation, we
speculated that a HDAC deacetylase is involved in GAPDH
FIGURE 3. PCAF is one of the acetyltransferases of GAPDH. A, overexpression of PCAF, but not other acetyltransferases, increases endogenous GAPDH K254
acetylation level. Indicated plasmids were expressed in HEK 293T cells. Endogenous acetylation levels of GAPDH were determined by anti-AcGAPDH (K254) antibody.
Relative ratios of GAPDH K254 acetylation were calculated from normalizing against GAPDH. B, overexpression of PCAF increases GAPDH K254 acetylation levels. The
indicated plasmids were expressed in HEK 293T cells, and the acetylation and protein levels were analyzed by Western blot. C, PCAF knockdown decreases endoge-
nous GAPDH acetylation at K254. A549 cells were transfected with siPCAF (four different oligos) or negative control (siNC) as previously described, and the acetylation
and protein levels were analyzed by Western blot (left panel). PCAF transcription level was measured by qPCR (right panel). D, exogenous GAPDH interacts with PCAF.
The indicated plasmids were expressed in HEK 293T cells and proteins were affinity purified. GAPDH and PCAF protein levels were determined against indicated
antibodies, respectively. E, endogenous GAPDH interacts with PCAF. Flag-PCAF was expressed in HEK 293T cells and proteins were affinity purified. GAPDH and PCAF
protein levels were determined against indicated antibodies, respectively. F, PCAF increases the enzyme activity of WT, but not mutants of GAPDH. The indicated
plasmids were expressed in HEK 293T cells and affinity purified. Different samples were analyzed by Western blot and enzyme activities were measured as described
in Fig. 2A. Mean values of relative enzyme activity of triplicate experimentsS.D. are presented. G, PCAF knockdown decreases endogenous GAPDH activity. HEK 293T
cells were transfected with siPCAF or negative control (siNC) as previously described and endogenous GAPDH were purified. Different samples were analyzed by
Western blot and enzyme activities were measured as described in Fig. 2A. Mean values of relative enzyme activity of triplicate experiments S.D. are presented.
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deacetylation. To identify the specific HDAC, we co-ex-
pressed GAPDH with seven HDAC deacetylases, HDAC 1–7
individually. We found that HDAC5, but not the other six
HDACs, decreased endogenous GAPDH K254 acetylation by
60% (Fig. 4A). Knocking down of HDAC5 by siRNA signifi-
cantly increased K254 acetylation level (by over 3-fold) (Fig.
4B). This data indicates that HDAC5 is a potential GAPDH
K254 deacetylase in vivo. We then performed Co-IP experi-
ments and found that HDAC5 readily not only co-precipi-
tated with the ectopically expressed GAPDH (Fig. 4C) but
FIGURE 4. HDAC5 is the deacetylase of GAPDH. A, HDAC5 deacetylates K254 of GAPDH. HA-tagged HDACs were expressed in HEK 293T cells, and endogenous
GAPDH proteins were purified. The acetylation and protein levels were analyzed by Western blot. Relative ratios of GAPDH K254 acetylation were calculated
from normalizing against GAPDH. B, knockdown of HDAC5 increases K254 acetylation level. HEK 293T cells were transfected with siHDAC5 or siNC as previously
described, and the acetylation and protein levels were analyzed by Western blot (left panel). HDAC5 transcription level was measured by qPCR (right panel). C,
exogenous GAPDH interacts with HDAC5. The indicated plasmids were expressed in HEK 293T cells, and proteins were affinity purified. GAPDH and HDAC5
protein levels were determined against indicated antibodies, respectively. D, endogenous GAPDH interacts with HDAC5. HA-tagged HDAC5 was expressed in
HEK 293T cells and proteins were affinity purified. GAPDH and HDAC5 protein levels were determined against indicated antibodies, respectively. E, HDAC5
decreases the enzyme activity of WT, but not mutants of GAPDH. The indicated plasmids were expressed in HEK 293T cells and purified by IP. Different samples
were analyzed by Western blot with indicated antibody, respectively. Enzyme activities were measured as described in Fig. 2A. Mean values of relative enzyme
activity of triplicate experiments S.D. are presented.
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also with the endogenous GAPDH (Fig. 4D), further sup-
porting a role of HDAC5 in GAPDH deacetylation.
To determine the functional significance of HDAC5 in
GAPDH regulation, we measured the enzyme activity of
GAPDH WT and mutants co-expressed with HDAC5 or not.
We observed that co-expression of HDAC5 decreased the
activity of GAPDHWT but had no significant effect on the activ-
ity of GAPDHK254Q or GAPDHK254R mutants (Fig. 4E). Collec-
tively, these data establish a specific and prominent role of
HDAC5 in GAPDH K254 deacetylation and enzymatic
inactivation.
Glucose Activates GAPDH by Stimulating K254 Acetylation—
GAPDH catalyzes an obligatory step in glycolysis. To deter-
mine if K254 acetylation of GAPDH is dynamically regulated in
vivo, we tested whether glucose affects GAPDH acetylation.
HEK 293T cells were cultured in medium with different glucose
conditions. We found that high glucose significantly increased
the acetylation levels of GAPDH K254 by more than 3-
fold (Fig. 5A, right panel). The acetylation of GAPDH K254 not
only increased with the increasing glucose concentration but
also with the extension of exposure time (Fig. 5A, left panel). To
determine the effect of glucose on GAPDH activity, HEK 293T
cells were transfected with Flag-GAPDH and maintained in 1.5
mM or 25 mM glucose. We found that the cells maintained in
high (25 mM) glucose media displayed GAPDH activity 40%
higher than cells maintained in low (1.5 mM) glucose media
(Fig. 5B). Notably, high glucose had no significant effect on the
acetylation level and enzyme activity of GAPDHK254Q (Fig. 5C).
We conclude that glucose stimulates GAPDH activity mainly
via increasing K254 acetylation.
We next examined the effect of glucose on the PCAF-
GAPDH interaction. Co-IP experiment showed that the inter-
action between PCAF and GAPDH was enhanced by nearly
3-fold under high glucose than under low glucose condition
(Fig. 5D). Notably, knocking down of PCAF blocked the
increase of GAPDH acetylation by glucose (Fig. 5E), suggesting
an important role of PCAF in mediating high glucose-stimu-
lated K254 acetylation in GAPDH. Furthermore, high glucose
decreased the interaction between HDAC5 and GAPDH by
60% (Fig. 5F). These data indicate that glucose stimulates
GAPDH K254 acetylation and activity mainly by increasing the
GAPDH-PCAF interaction and decreasing the GAPDH-
HDAC5 interaction.
K254Q Inhibits the Function of GAPDH in Supporting Cell
Proliferation—Elevated GAPDH protein levels are reported in
different types of cancer cells, especially in lung cancer (4, 19).
As a required enzyme in glycolysis, GAPDH is essential for cell
growth in vitro and in vivo. We investigated the effect of
GAPDH acetylation on cell proliferation and tumor growth.
We generated GAPDH knock down and put back stable cell
lines in the lung cancer cell line A549. First, the endogenous
GAPDH was knocked down by shRNA and then the shRNA-
resistant GAPDHWT and GAPDHK254Q were stably expressed
in the knock down cells. Western blotting analysis demon-
strated that the endogenous GAPDH was effectively knocked
down. GAPDHWT and GAPDHK254Q were expressed at a level
similar to the endogenous GAPDH (Fig. 6A). We observed
that A549/GAPDHWT cells proliferated faster than A549/
GAPDHK254Q cells (Fig. 6B), indicating a growth reduction
conferred by the mutant at K254. The CCK8 assay also showed
that A549/GAPDHWT cells had a prominent growth advantage
over the A549/GAPDHK254Q cells (Fig. 6C).
To determine whether the K254Q expressing cells have a
growth disadvantage in vivo, we performed a xenograft study
using the A549 cell lines generated above. Five million A549/
GAPDHWT and A549/GAPDHK254Q cells were injected into
nude mice and tumor cell growth was monitored over a period
of 7 weeks. Sustained expression of Flag-tagged GAPDH WT
and K254Q mutant in xenograft tumors was verified by West-
ern blot (Fig. 6D). We found that tumors developed in mice
injected with A549/GAPDHWT cells were significantly (p 
0.0001) larger than those injected with A549/GAPDHK254Q
cells (Fig. 6, E and F). The difference in tumor volume of cells
expressing wild-type or K254Q mutant GAPDH remained sta-
tistically significant (p  0.0001) even when the largest tumor
sample of the wild type expressing cells was excluded. A549/
GAPDHK254Q cells also displayed tumor weight significantly
(p  0.0001) lighter than the A549/GAPDHWT cells (Fig. 6G).
Taken together, our results suggest a positive role of GAPDH
K254 acetylation in modulating cell growth.
DISCUSSION
The GAPDH gene encodes a single mRNA leading to the
production of a single protein without any alternative splicing.
However, accumulating evidence reveals its diverse functions
in various cellular processes (7–14). In this report, we identified
a novel acetylation site (K254) in GAPDH. More interestingly,
K254 acetylation is stimulated by high glucose, leading to the
increase of GAPDH enzyme activity, eventually promote the
cell proliferation and tumor formation. This reveals a potential
mechanism of cellular metabolic adaptation to environmental
conditions.
The protein acetylation modification is a reversible process
via the control of acetyltransferase and deacetylase. The pro-
teins that can add the acetyl group to the -amino group of
lysine are called histone acetyltransferases (HATs) (20) and
many HATs have more than one substrates and one substrate
may have more than one HATs. Here we reported PCAF is
one of the acetyltransferases of GAPDH. Other HATs might be
involved in acetylating GAPDH. Similarly to the HATs, histone
deacetylases (HDACs) also deacetylate many non-histone pro-
teins. The classical HDAC family includes three phylogenetic
classes, namely class I, II and class IV. Class I HDACs have
homology to the yeast transcriptional regulator Rpd3 and com-
prises HDAC1, -2, -3, and -8, all of which are located in the
nucleus. Class II HDACs (HDAC4, -5, -6, -7, -9, and -10) show
homology to yeast Hda1 and all of them can be localized in both
the nucleus and the cytoplasm (21). Class IV has only one mem-
ber-HDAC11, which was newly found. Here we tested the over-
expression of HDAC 1–7 and found that HDAC5 deacetylates
GAPDH at K254 and reduces its enzyme activity. For many
substrates can be deacetylated by more than one HDAC (21); it
is possible that other HDACs could also deacetylate GAPDH at
different sites.
Rapidly proliferating cancer cells showed a high glucose
uptake and glycolysis was dramatically elevated (22). Here we
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FIGURE 5. Glucose increases the GAPDH K254 acetylation and enzyme activity. A, high glucose increases GAPDH acetylation at K254 in time and dose-de-
pendent manner. HEK 293T cells were cultured with 25 mM glucose medium for various time lengths as indicated (left panel), or with different concentrations
of glucose for 6 h (right panel) and endogenous GAPDH protein and acetylation levels were determined against indicated antibodies, respectively. Relative
ratios of GAPDH K254 acetylation were calculated from normalizing against GAPDH. B, high glucose increases the activity of GAPDH. Flag-GAPDH was
expressed in HEK 293T cells and maintained under indicated glucose concentrations. Different samples were analyzed for acetylation levels and enzyme
activities were measured as described in Fig. 2A. Relative ratios of acetylation were calculated from normalizing against Flag-GAPDH. Mean values of relative
enzyme activity of triplicate experiments S.D. are presented. C, high glucose increases the activity of GAPDHWT not the GAPDHK254Q. The indicated plasmids
were expressed in HEK 293T cells and the cells were maintained under indicated glucose concentrations. Different samples were analyzed for acetylation levels
and enzyme activities as described in Fig. 2A. Relative ratios of acetylation were calculated from normalizing against Flag-GAPDH. Mean values of relative
enzyme activity of triplicate experiments S.D. are presented. D, GAPDH-PCAF interaction is enhanced under high glucose. Myc-GAPDH and Flag-PCAF were
co-expressed in HEK 293T cells. The interaction between GAPDH and PCAF was determined by IP-Western. The Co-IP efficiency of Myc-GAPDH was calculated
from normalizing against Flag-PCAF. E, PCAF knockdown blocks the increase of GAPDH acetylation level induced by high glucose. HEK 293T cells were
maintained in 1.5 mM or 25 mM glucose for 6 h after transfected with siPCAF (two different oligos) or siNC as previously described. The proteins and acetylation
levels were analyzed by Western blot. Relative ratios of acetylation were calculated from normalizing against GAPDH. F, GAPDH-HDAC5 interaction is
decreased under high glucose. Flag-GAPDH and HA-HDAC5 were co-expressed in HEK 293T cells. The interaction between GAPDH and HDAC5 was determined
by IP-Western. The Co-IP efficiency of HA-HDAC5 was calculated from normalizing against Flag-GAPDH.
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found upon high glucose, the interaction between PCAF and
GAPDH is increased while the binding between HDAC5 and
GAPDH is decreased, promoting K254 acetylation and its
enzyme activity. In contrast, upon low glucose, the binding
between HDAC5 and GAPDH is increased while the interac-
tion between PCAF and GAPDH is decreased, repressing K254
acetylation and its enzyme activity. Mutants at K254 to gluta-
mine or arginine are defective of acetylation and cannot
FIGURE 6. Acetylation of GAPDH at K254 promotes tumor cell proliferation. A, verification of GAPDH expressing A549 stable cell lines. A549 cells stably
expressed GAPDHWT and GAPDHK254Q were transfected with shRNA-resistant WT or K254Q of GAPDH thus the knockdown and put back stable cells were
generated. GAPDH knockdown efficiency and re-expression level were determined by Western blot. B, GAPDHK254Q is compromised to support cell prolifera-
tion. GAPDHWT and GAPDHK254Q cells were seeded as the same number in each well. Cell numbers were counted every 24 h. Error bars represent cell numbers
S.D. for experiments performed in triplicate. C, absorbance at 450 nm was measured after adding CCK-8 solution to each well of the plate and incubating for
2 h. Error bars represent cell numbers S.D. for experiments performed in triplicate. D, expression of GAPDHWT and GAPDHK254Q in xenograft. Whole cell lysate
were prepared from either original stable A549/GAPDHWT and A549/GAPDHK254Q pools or xenograft tumors, followed by Western blot. E—G, GAPDHK254Q is
defective in supporting tumor growth in vivo. Xenograft was performed using the A549 cell lines characterized in A. 7 weeks after injection, mice were sacrificed
and tumors were extracted and photographed (E). Tumor diameters were measured, and the volumes were calculated (F). Tumor weight was measured (G). The
p value was calculated by paired t test.
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response to the glucose status change or the effect of PCAF
and HDAC5. Consistently, compared with A549/GAPDHWT,
A549/GAPDHK254Q showed a reduction in cell proliferation
and tumor growth in vivo. Our study reveals a molecular mech-
anism of GAPDH regulation by K254 acetylation via the action
of PCAF and HDAC5 in response to extracellular environment,
indicating K254 acetylation of GAPDH might be readout of
cellular glucose status.
Modification of GAPDH by S-nitrosylation, acetylation, and
phosphorylation has been linked to nuclear translocation of
GAPDH (23–25). During apoptosis, the activated inducible
nitric oxide synthase (iNOS) or neuronal NOS (nNOS) could
generate nitric oxide (NO) S-nitrosylating GAPDH to promote
its binding with Siah1, an E3-ubiquitin-ligase with a nuclear
localization signal (NLS) (23). Nuclear GAPDH is acetylated at
lysine 160 by the acetyltransferase p300/CBP, which in turn
stimulates the acetylation and catalytic activity of p300/CBP
(26). In addition, it is also reported that Sirt1 restrains GAPDH
entering nuclear via direct interaction with GAPDH in a
deacetylase activity-independent manner (27). It is an open
question whether K254 acetylation affects the nuclear translo-
cation of GAPDH.
GAPDH is dramatically elevated in various human cancers
and often associated with reduced survival (4, 28 –30). Our
study demonstrated that the critical role of acetylation regula-
tion of GAPDH in the coordination of glucose utilization to
promote cell growth and tumorigenesis. Regarding the promo-
tive effect of K254 acetylation on GAPDH, drugs inhibiting
GAPDH acetylation by targeting the acetyltransferase or
deacetylase should inhibit GAPDH, therefore may have poten-
tial therapeutic value for cancers with high GAPDH activity.
Collectively, our study not only identifies a novel site of
GAPDH acetylation regulation, but also provides a potential
therapeutic target for GAPDH overexpressed cancers.
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